Valuation: Zoetis Inc.

Capitalization 52.29B 44.95B 42.11B 39.25B 72.49B 4,706B 78.85B 492B 190B 2,223B 196B 192B 8,126B P/E ratio 2025 *
19.8x
P/E ratio 2026 * 18.5x
Enterprise value 56.77B 48.8B 45.71B 42.61B 78.7B 5,109B 85.6B 535B 206B 2,413B 213B 209B 8,823B EV / Sales 2025 *
6.01x
EV / Sales 2026 * 5.68x
Free-Float
88.45%
Yield 2025 *
1.67%
Yield 2026 * 1.86%
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.46%
1 week-7.43%
Current month-7.43%
1 month-1.53%
3 months-22.61%
6 months-29.63%
Current year-27.18%
More quotes
1 week 118.47
Extreme 118.47
129.58
1 month 115.25
Extreme 115.25
129.58
Current year 115.25
Extreme 115.25
177.4
1 year 115.25
Extreme 115.25
181.85
3 years 115.25
Extreme 115.25
201.92
5 years 115.25
Extreme 115.25
249.27
10 years 38.26
Extreme 38.26
249.27
More quotes
Manager TitleAgeSince
Chief Executive Officer 53 2019-12-31
Director of Finance/CFO 53 2021-05-31
Chief Operating Officer 52 2024-07-31
Director TitleAgeSince
Chairman 67 2012-06-30
Director/Board Member 67 2012-12-31
Chairman 72 2013-06-25
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-1.46%-7.43%-32.11%-23.61% 52.29B
-0.41%-5.89%+80.69%+70.43% 10.88B
+0.14%-3.12%+13.54%+43.46% 3.47B
+2.01%-0.11%-16.76%+0.22% 3.47B
+3.08%+9.66%+93.92%+45.81% 2.07B
+1.00%+0.60%-26.51%-14.19% 1.69B
-3.95%-6.49%+70.86%+217.34% 1.59B
-0.21%-3.12%-6.70%-8.47% 1.24B
+0.88%+2.83%+12.22%-39.61% 1.15B
+3.59%+2.32%-4.34%-13.99% 1.03B
Average +0.47%-0.84%+18.48%+27.74% 7.89B
Weighted average by Cap. -0.85%-5.66%-6.95%+0.36%
See all sector performances

Financials

2025 *2026 *
Net sales 9.45B 8.12B 7.61B 7.09B 13.09B 850B 14.24B 88.96B 34.35B 401B 35.45B 34.69B 1,468B 9.94B 8.54B 8B 7.46B 13.77B 894B 14.98B 93.58B 36.13B 422B 37.29B 36.49B 1,544B
Net income 2.68B 2.31B 2.16B 2.01B 3.72B 242B 4.05B 25.28B 9.76B 114B 10.07B 9.86B 417B 2.83B 2.43B 2.28B 2.12B 3.92B 255B 4.27B 26.65B 10.29B 120B 10.62B 10.39B 440B
Net Debt 4.48B 3.85B 3.61B 3.36B 6.21B 403B 6.75B 42.19B 16.29B 190B 16.81B 16.45B 696B 4.15B 3.56B 3.34B 3.11B 5.75B 373B 6.25B 39.05B 15.08B 176B 15.56B 15.23B 644B
More financial data * Estimated data
Logo Zoetis Inc.
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - companion animal (67.8%): cats and dogs (95.5% of net sales) and horses (4.5%); - livestock (31.3%): cattle (52.8% of sales), poultry (18.2%), swine (17.8%), fish (8.4%) and other (2.8%); - other (0.9%). Net sales break down by family of products into parasiticides (23.3%), vaccines (19.7%), dermatological products (17.9%), anti-infectives (11.9%), pain relievers (9.2%), diagnostic products (4.2%), medicated feed additives (3.2%) and other (10.6%). At the end of 2024, the group has 22 production sites worldwide. The United States accounts for 54.8% of net sales.
Employees
13,800
More about the company
Date Price Change Volume
25-12-05 118.65 $ -1.46% 4,279,887
25-12-04 120.41 $ -1.76% 4,939,186
25-12-03 122.57 $ -1.50% 5,019,981
25-12-02 124.44 $ -2.21% 6,896,977
25-12-01 127.25 $ -0.73% 4,207,090

Delayed Quote Nyse, December 05, 2025 at 04:00 pm EST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
118.65USD
Average target price
165.36USD
Spread / Average Target
+39.37%
Consensus

Quarterly revenue - Rate of surprise